Marieke Krol
Marieke Krol
IQVIA, Erasmus Universiteit Rotterdam
Verified email at iqvia.com
Title
Cited by
Cited by
Year
Productivity costs in economic evaluations: past, present, future
M Krol, W Brouwer, F Rutten
Pharmacoeconomics 31 (7), 537-549, 2013
1622013
The iMTA productivity cost questionnaire: a standardized instrument for measuring and valuing health-related productivity losses
C Bouwmans, M Krol, H Severens, M Koopmanschap, W Brouwer, ...
Value in health 18 (6), 753-758, 2015
1572015
How to estimate productivity costs in economic evaluations
M Krol, W Brouwer
Pharmacoeconomics 32 (4), 335-344, 2014
1282014
Does including informal care in economic evaluations matter? A systematic review of inclusion and impact of informal care in cost-effectiveness studies
M Krol, J Papenburg, J van Exel
Pharmacoeconomics 33 (2), 123-135, 2015
982015
Costs, quality of life, treatment satisfaction and compliance in patients with β-thalassemia major undergoing iron chelation therapy: the ITHACA study
L Scalone, LG Mantovani, M Krol, D Rofail, S Ravera, M Grazia Bisconte, ...
Current medical research and opinion 24 (7), 1905-1917, 2008
972008
Do productivity costs matter?
M Krol, J Papenburg, M Koopmanschap, W Brouwer
Pharmacoeconomics 29 (7), 601-619, 2011
852011
Handleiding iMTA medical cost questionnaire (iMCQ)
C Bouwmans, L Hakkaart-van Roijen, M Koopmanschap, M Krol, ...
Rotterdam: iMTA, Erasmus Universiteit Rotterdam, 2013
572013
Productivity cost calculations in health economic evaluations: correcting for compensation mechanisms and multiplier effects
M Krol, WBF Brouwer, JL Severens, J Kaper, SMAA Evers
Social science & medicine 75 (11), 1981-1988, 2012
512012
In or out? Income losses in health state valuations: a review
C Tilling, M Krol, A Tsuchiya, J Brazier, W Brouwer
Value in Health 13 (2), 298-305, 2010
452010
SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness …
R Riemsma, M Al, IC Ramos, SN Deshpande, N Armstrong, YC Lee, ...
Health Technology Assessment (Winchester, England) 17 (61), 1, 2013
372013
Productivity Costs in Health-State Valuations
M Krol, W Brouwer, P Sendi
Pharmacoeconomics 24 (4), 401-414, 2006
372006
A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs
M Krol, J Papenburg, SS Tan, W Brouwer, L Hakkaart
The European Journal of Health Economics 17 (4), 391-402, 2016
302016
Value for money: economic evaluation of two different caries prevention programmes compared with standard care in a randomized controlled trial
JH Vermaire, C Van Loveren, WBF Brouwer, M Krol
Caries research 48 (3), 244-253, 2014
292014
The impact of patients’ subjective life expectancy on time tradeoff valuations
E Heintz, M Krol, LÅ Levin
Medical Decision Making 33 (2), 261-270, 2013
272013
Handleiding iMTA productivity cost questionnaire (iPCQ)
C Bouwmans, L Hakkaart-van Roijen, M Koopmanschap, M Krol, ...
Rotterdam: iMTA, Erasmus Universiteit, 2013
272013
A systematic review of economic analyses of pharmaceutical therapies for advanced colorectal cancer
M Krol, M Koopman, C Uyl-de Groot, CJA Punt
Expert opinion on pharmacotherapy 8 (9), 1313-1328, 2007
252007
Breaking the silence: exploring the potential effects of explicit instructions on incorporating income and leisure in TTO exercises
M Krol, P Sendi, W Brouwer
Value in health 12 (1), 172-180, 2009
242009
Breaking the silence: exploring the potential effects of explicit instructions on incorporating income and leisure in TTO exercises
M Krol, P Sendi, W Brouwer
Value in health 12 (1), 172-180, 2009
242009
Unpaid work in health economic evaluations
M Krol, W Brouwer
Social Science & Medicine 144, 127-137, 2015
232015
Predicting productivity based on EQ-5D: an explorative study
M Krol, E Stolk, W Brouwer
The European Journal of Health Economics 15 (5), 465-475, 2014
222014
The system can't perform the operation now. Try again later.
Articles 1–20